• The role of magnesium in humans and the effect of reduced magnesium on the quality of life of children with gastro-esophageal reflux disease
Come back

The role of magnesium in humans and the effect of reduced magnesium on the quality of life of children with gastro-esophageal reflux disease

SOVREMENNAYA PEDIATRIYA.2019.1(97):124-130; doi 10.15574/SP.2019.97.124

Marushko Iu. V., Аsonov А. О., Hyschak T. V.
Bogomolets National Medical University, Kyiv, Ukraine

Among the pathologies of element status in Ukraine's population magnesium deficiency occupies a leading position. Very often this deficiency appears in childhood and adolescence, when due to intensive child development increased magnesium need not meet his admission with food. The article presents literature data and the results of individual studies authors demonstrate feasibility of determining the level of magnesium in many somatic diseases and the need for timely correction of magnesium deficiency. Correction of magnesium deficiency by using organic salts of magnesium and pyridoxine (Magne-B6®) improves cellular metabolism and energy supply, stabilizing the membrane and the formation of physiological conditions for the perception of body cells specific treatment of the underlying disease. The use of Magne-B6® base can influence the pathogenesis of many diseases associated with magnesium deficiency, with disturbances of the energy and electrolyte metabolism and help restore adaptive reserves of the organism.

Key words: magnesium deficiency, children, Magne-B6®.

REFERENCES

1. Akarachkova ES, Vershinina SV, Kotova OV, Ryabokon IV. (2013). Osnovyi terapii i profilaktiki stressa i ego posledstviy u detey i podrostkov. Voprosyi sovr pediatrii. 3: 38–44.

2. Akarachkova ES, Vershinina SV, Kotova OV, Ryabokon IV. (2014). Algoritm diagnostiki, lecheniya i profilaktiki stressa i stress-svyazannyih rasstroystv u detey i podrostkov. Voprosyi praktich. pediatrii. 6: 24–31.

3. Akarachkova ES, Vershinina SV. (2013). Rol magniya v protsessah neyroprotektsii i neyroplastichnosti. Zhurnal nevrologii i psihiatrii im SS Korsakova. 2: 80–83.

4. Arushanyan EB, Beyer EV. (2012). Gormon mozgovoy zhelezyi epifiza melatonin — universalnyiy estestvennyiy adaptogen. Uspehi fiziol nauk. 43; 2: 82–100.

5. Babanov SA. (2015). Mag po imeni Magniy. Novaya apteka. 4: 70.

6. Bychkov MA, Yakhnytska MM. (2016). Osoblyvosti vmistu elektrolitiv u shlunkovomu soku khvorykh na hastroezofahalnu refleksnu khvorobu. Ukraina Zdorovia natsii. 1–2(37-38): 16–18.

7. Burchinskiy SG. (2013). Melatonin i ego vozmozhnosti v nevrologicheskoy praktike. Ukrayinskiy visn psihonevrol. 21; 1(74): 112–117.

8. Vyatkina IS, Labyigina AV, Suturina LV i dr. (2014). Defitsit magniya i pokazateli trevozhnosti u devushek-studentok. Reproduktivnoe zdorove detey i podrostkov. 2: 94–99.

9. Hyshchak TV, Marushko YuV. (2011). Obmin mahniiu u ditei ta rol defitsytu mahniiu u klinichnii praktytsi. Sovremennaya pediatriya. 5(39): 89–93.

10. Gromova OA, Egorova EYu, Torshin IYu i dr. (2010). Perspektivyi primeneniya magniya v pediatrii i detskoy nevrologi. Zhurnal Pediatrii im GN Speranskogo. 7: 9–14.

11. Gromova OA, Kalacheva AG, Torshin IYu i dr. (2013). Kaliysberegayuschie svoystva magniya. Kardiologiya. 10: 38–48.

12. Gromova OA, Kalacheva AG, Torshin IYu i dr. (2014). Diagnostika defitsita magniya. Kontsentratsii magniya v biosubstratah v norme i pri razlichnoy patologi. Kardiologiya. 10: 63–71.

13. Gromova OA, Torshin IYu, Volkov AYu, Sherbo SN. (2014). Znachenie dlya klinicheskoy praktiki ranney diagnostiki defitsita magniya pri opredelenii ego v razlichnyih biosubstratah. Rossiyskiy vestn akushera-ginekologa. 5: 101–110.

14. Gromova OA, Torshin IYu, Kalacheva AG i dr. (2009). Dinamika kontsentratsii magniya v krovi posle priema razlichnyih magnesoderzhaschih preparatov. Farmateka. 10: 63–68.

15. Gromova OA, Torshin IYu, Rudakov KV. (2014). Sistematicheskiy analiz magniyzavisimyih mitohondrialnyih belkov. Kardiologiya. 9: 86–92.

16. Gromova OA, Torshin IYu, Yudina NV i dr. (2014). Defitsit magniya i narusheniya regulyatsii tonusa sosudov. Kardiologiya. 7: 66–72.

17. Gromova OA, Fedotova LE, Grishina TR i dr. (2014). Rol magniya v formirovanii metabolicheskogo sindroma, korrektsii izbyitochnogo vesa i ozhireniya u detey i podrostkov. Pediatriya. 2: 123–133.

18. Gromova OA, Fedotova LE, Kalacheva AG i dr. (2013). Defitsit magniya kak problema stressa i dezadaptatsii u detey. Pediatriya. 5: 110–121.

19. Gromova OA. (2014). Defitsit magniya kak problema sovremennogo pitaniya u detey i podrostkov. Pediatricheskaya farmakol. 1: 20–30.

20. Gromova YuA, Torshin IYu, Kalacheva AG, Grishina TR. (2016). O sinergizme kaliya i magniya v podderzhanii funktsii mIokarda. Kardiologiya. 3: 73–80.

21. Drapkina OM, Gegenava BB. (2014). Defitsit magniya v kardiologii. Terapevticheskiy arhiv. 12: 104–106.

22. Kalacheva AG, Gromova OA, Kerimkulova NV i dr. (2012). Narusheniya formirovaniya soedinitelnoy tkani u detey kak sledstvie defitsita magniya. Lechaschiy vrach. 3: 59–64.

23. Каркашадзе ГА, Намазова-Баранова ЛС, Мамедьяров АМ и др. (2014). Дефицит магния в детской неврологии: что нужно знать педиатру? Вопросы совр педиатрии. 5: 17–25.

24. Kvashnina LV. (2016). Vliyanie defitsita magniya na formirovanie «bolezney tsivilizatsii» u detey. Zdorov'ya UkraYini. Tematichniy nomer: 14–15.

25. Maidannyk VH, Smiian OI, Bynda TP, Savelieva-Kulyk NO. (2013). Kliniko-patohenetychna kharakterystyka vehetatyvnykh dysfunktsii ta yikh likuvannia u ditei. Navchalnyi posibnyk. Sumy: Sumskyi derzh. u-t: 173.

26. Makarova TP, Habibrahmanova ZR, Sadyikova DI, Chilikina YuM. (2012) Sostoyanie elementnogo gomeostaza u detey i podrostkov s essentsialnoy arterialnoy gipertenziey. Kazanskiy med zhurn. 2: 184–190.

27. Martyinov AI, Urlaeva IV, Akatova EV, Nikolin OP. (2014). Znachenie defitsita magniya v kardiologii. Consilium medicum. 1: 43–46.

28. Marushko YuV, Hyshchak TV. (2012). Korektsiia nedostatnosti mahniiu u ditei ta pidlitkiv z astenichnym syndromom ta pervynnoiu arterialnoiu hipertenziieiu. Metodychni rekomendatsii dlia likariv. Kyiv: 29.

29. Marushko YuV, Hyshchak TV. (2013). Efektyvnist zastosuvannia Mahne-V6 pry astenichnomu syndromi i porushenniakh nichnoho snu u ditei. Sovremennaya pediatriya. 6(53): 37–44.

30. Marushko YuV, Hyshchak TV. (2013). Korektsiia defitsytu mahniiu u ditei ta pidlitkiv z astenichnym syndromom. Problemni pytannia diahnostyky ta likuvannia ditei z somatychnoiu patolohiieiu. Materialy nauk.-prakt. konf. z mizhnar. uch., Kharkiv, 28 ber. 2013. Kharkiv: 20–22.

31. Marushko YuV, Hyshchak TV. (2014). Systemni mekhanizmy adaptatsii. Stres u ditei. Monohrafiia. Kyiv: 138.

32. Mubarakshina OA, Somova MN. (2014). Preparatyi magniya v kompleksnoy terapii i profilaktike serdechno-sosudistyih zabolevaniy. Farmateka. 9: 55–58.

33. Nemkova SA, Maslova OI, Zavadenko NN i dr. (2015). Kompleksnaya diagnostika i korrektsiya narusheniy sna u detey. Pediatricheskaya farmakologiya. 2: 180–189.

34. Rahmanov RS, Razgulin SA, Tarasov AV. (2014). Otsenka vitaminno-mineralnogo statusa i gumoralnogo immuniteta yunoshey pri psihosotsialnoy adaptatsiii akklimatizatsii. Meditsinskiy alm. 2: 149–151.

35. Spasov AA, Zheltova A, Haritonova MV. (2012). Magniy i okislitelnyiy stress. Rossiyskiy fiziologich. zhurn. 7: 915–923.

36. Spasov AA, Haritonova MV, Iezhitsa IN i dr. (2012). Funktsionalnyie rezervyi serdtsa v usloviyah alimentarnogo defitsita magniya. Kardiologiya. 10: 39–44.

37. Tarasov EA, Blinov DV, Zimovina UV, Sandakova EA. (2015). Defitsit magniya i stress: voprosyi vzaimosvyazi, testyi dlya diagnostiki i podhodyi k terapii. Terapevticheskiy arh. 9: 114–122.

38. Shkolnikova MA, Kleymenova NI, Dikevich EP, Erastova EK. (2011). Primenenie preparatov magniya pri lechenii narusheniy ritma serdtsa u detey. Rossiyskiy vestn perinatol i pediatrii. 2: 63–68.

39. Abbasi B. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 17(12): 1161–1169. PMid:23853635 PMCid:PMC3703169

40. Akata T. (2007). Cellular and molecular mechanisms regulating vascular tone. Part 1: basic mechanisms controlling cytosolic Ca2+ concentration and the Ca2+-dependent regulation of vascular tone. J Anesth. 21: 220–231. https://doi.org/10.1007/s00540-006-0488-4; https://doi.org/10.1007/s00540-006-0487-5; PMid:17458652

41. Astor MC, Lovas K, Wolff AS et al. (2015). Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. Endocr Connect. 4(4): 215–222. https://doi.org/10.1530/EC-15-0066; PMid:26273099 PMCid:PMC4566842

42. Coulter M, Colvin C, Korf B et al. (2015). Hypomagnesemia due to two novel TRPM6 mutations. J Pediatr Endocrinol Metab. 1; 28(11-12): 1373–1378.

43. Guerrero-Romero F, Rodriguez-Moran M, Hernandez-Ronquillo G et al. (2016). Low Serum Magnesium Levels and Its Association with High Blood Pressure in Children. J Pediatr. 168: 93–98. https://doi.org/10.1016/j.jpeds.2015.09.050; PMid:26490130

44. Jin K, Kim TH, Kim YH, Kim YW. (2013). Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats. Korean J Intern Med. 28(2): 197–205. https://doi.org/10.3904/kjim.2013.28.2.197; PMid:23526071 PMCid:PMC3604610

45. Katayama K, Povalko N, Yatsuga S et al. (2015). New TRPM6 mutation and management of hypomagnesaemia with secondary hypocalcaemia. Brain Dev. 37(3): 292–298. https://doi.org/10.1016/j.braindev.2014.06.006; PMid:24985022

46. Mdel C Morales-Ruan, Villalpando S, Garcia-Guerra A et al. (2012). Iron, zinc, copper and magnesium nutritional status in Mexican children aged 1 to 11 years. Slud Publica Mex. 54(2): 125–134. https://doi.org/10.1590/S0036-36342012000200008

47. Mortazavi M, Moeinzadeh F, Saadatnia M et al. (2013). Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol. 69(5): 309–316. https://doi.org/10.1159/000346427; PMid:23548855

48. Ozmen H, Akarsu S, Polat F, Cukurovali A. (2013). The levels of calcium and magnesium, and of selected trace elements, in whole blood and scalp hair of children with growth retardation. Iran J Pediatr. 23(2): 125–130. PMid:23724170 PMCid:PMC3663300

49. Rodriguez-Ramirez M, Simental-Mendia LE, Gonzalez-Ortiz M et al. (2015). Prevalence of Prehypertension in Mexico and Its Association With Hypomagnesemia. Am J Hypertens. 28(8): 1024–1030. https://doi.org/10.1093/ajh/hpu293; PMid:25618517

50. Rotter I, Kosik-Bogacka D, Dolegowska B et al. (2015). Relationship between serum magnesium concentration and metabolic and hormonal disorders in middleaged and older men. Magnes Res. 28(3): 99–107. PMid:26507751

51. Rubio-Lopez N, Morales-Suarez-Varela M, Pico Y et al. (2016). Nutrient Intake and Depression Symptoms in Spanish Children: The ANIVA Study. Int J Environ Res Public Health. 22: 13–16. https://doi.org/10.3390/ijerph13030352

52. Saha H, Harmoinen A, Karvonen AL et al. (1998). Serum ionized versus total magnesium in patients with intestinal or liver disease. Clin Chem Lab Med. 36(9): 715–718. https://doi.org/10.1515/CCLM.1998.126; PMid:9804396

53. Sanchez-Morito N, Planells E, Aranda P, Llopis J. (2000). Influence of magnesium deficiency on the bioavailability and tissue distribution of iron in the rat. J Nutr Biochem. 11(2): 103–108. https://doi.org/10.1016/S0955-2863(99)00076-5

54. Sarrafzadegan N, Khosravi-Boroujeni H, Lotfizadeh M et al. (2016). Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. Nutrition. 32(4): 409–417. https://doi.org/10.1016/j.nut.2015.09.014; PMid:26919891

55. Tomaschitz A, Ritz E, Pieske B et al. (2014). Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism. 63(1): 20–31. https://doi.org/10.1016/j.metabol.2013.08.016; PMid:24095631

56. Varni JW, Limbers CA, Burwinkle TM. (2007). Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales. Health and Quality of Life Outcomes. 5: 43. https://doi.org/10.1186/1477-7525-5-43; PMCid:PMC1964786

57. Zaher MM, Abdel-Salam M, Abdel-Salam R et al. (2016). Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis. Saudi J Kidney Dis Transpl. 27(2): 233–240. https://doi.org/10.4103/1319-2442.178205; PMid:26997375

Article received: Sep 21, 2018. Accepted for publication: Jan 10, 2019.